Clik here to view.
CMS taps IT firm CGI for Sunshine Act Data Dump
Shantanu Agrawal, director, data sharing & partnership group, Center for Program Integrity, CMS Speaking at CBI’s Sunshine & Aggregate Spend Conference in Washington DC on Tuesday, Shantanu...
View ArticlePharma Revenues, Health Expenditures Set to Increase
Healthcare spending will rise modestly in the US over the next decade, as economic growth picks up, health reform provides expanded coverage, and the population continues to age, according to an annual...
View ArticleCo-Pay Offset Programs and Health Insurance Marketplaces: Causes for Concern
Co-Pay Offset Programs and Health Insurance Marketplaces As the health insurance marketplaces begin enrollment next week and go-live on January 1, 2014, several issues continue to be a source of...
View ArticleThe First Day of Obamacare: Is US Pharma Ready?
by Tom Norton For more than three years, the US pharmaceutical industry has known that today would arrive. So this is it. The first day that eligible U.S. citizens can sign up for Obamacare — and enjoy...
View ArticleCo-Pay Offset Programs and the New Health Insurance Marketplace: Will the...
By Mark McAndrew. As the health insurance marketplaces begin enrollment this week and go live on January 1, 2014, several issues continue to be a source of significant confusion to manufacturers,...
View ArticleClik here to view.
Putting a Price Tag on Compliance: Cheap Change or Big Bucks?
John Kamp, Executive Director, Coalition for Healthcare Communication Compliance rules under the US Physician Payments Sunshine Act have been criticized for the excruciating level of detail demanded...
View ArticleDrug Reimbursement: Make Room at the Table for Patients and Researchers
At last week’s Partnering for Cures conference held in New York City, several expert panels discussed new angles of approaching solutions to disease, encouraging investment and mitigating...
View ArticleConfessions of a Compliance Director
In anticipation of CBI’s (a PharmExec sibling company) 11th Annual Pharma Compliance Congress happening later this month, PharmExec spoke with a compliance director at a mid-sized pharma ($5 billion in...
View ArticleObama Administration Halts Attack on Medicare Drug Plans
In an abrupt about-face, the Obama administration halted its ill-timed effort to launch an overhaul of the Medicare Part D program and announced it would not pursue changes in some key rules as...
View ArticleMedicare Payment Data Raises Questions About Drug Costs
Even though the just-released Medicare data on payments to individual doctors doesn’t provide specifics on prescription drug outlays, it opens the door to sharp scrutiny of Medicare reimbursement for...
View Article
